{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:13:54Z","timestamp":1762143234205,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","award":["1I01BX002061","1IK6BX004209","2I01BX000226"],"award-info":[{"award-number":["1I01BX002061","1IK6BX004209","2I01BX000226"]}],"id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013467","name":"Association of Avian Veterinarians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013467","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P50DA018165","R41DA039632"],"award-info":[{"award-number":["P50DA018165","R41DA039632"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejphar.2020.173175","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T12:16:26Z","timestamp":1589372186000},"page":"173175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Partial MHC\/neuroantigen peptide constructs attenuate methamphetamine-seeking and brain chemokine (C\u2013C motif) ligand 2 levels in rats"],"prefix":"10.1016","volume":"880","author":[{"given":"Jennifer M.","family":"Loftis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommy","family":"Navis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulziibat","family":"Person","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Matthew","family":"Lattal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur A.","family":"Vandenbark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee","family":"Shirley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Huckans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173175_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nn872","article-title":"Neurobiological evidence for hedonic allostasis associated with escalating cocaine use","volume":"5","author":"Ahmed","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173175_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1126\/science.282.5387.298","article-title":"Transition from moderate to excessive drug intake: change in hedonic set point","volume":"282","author":"Ahmed","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2020.173175_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugalcdep.2017.08.003","article-title":"Glial and neuroinflammatory targets for treating substance use disorders","volume":"180","author":"Bachtell","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2020.173175_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/cne.20598","article-title":"Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1\/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides","volume":"489","author":"Banisadr","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2020.173175_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2010.04.010","article-title":"The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse","author":"Beardsley","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173175_bib6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuint.2016.10.007","article-title":"Partial MHC class II constructs as novel immunomodulatory therapy for stroke","volume":"107","author":"Benedek","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2020.173175_bib7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.drugalcdep.2017.05.016","article-title":"Ibudilast may improve attention during early abstinence from methamphetamine","volume":"178","author":"Birath","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2020.173175_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2005.06.026","article-title":"Perturbation of chemokine networks by gene deletion alters the reinforcing actions of ethanol","author":"Blednov","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2020.173175_bib9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1601-183X.2012.00780.x","article-title":"Behavioral actions of alcohol: phenotypic relations from multivariate analysis of mutant mouse data","volume":"11","author":"Blednov","year":"2012","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.ejphar.2020.173175_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1369-1600.2010.00284.x","article-title":"Neuroimmune regulation of alcohol consumption: behavioral validation of genes obtained from genomic studies","volume":"17","author":"Blednov","year":"2012","journal-title":"Addiction Biol."},{"key":"10.1016\/j.ejphar.2020.173175_bib11","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.4049\/jimmunol.164.12.6366","article-title":"Regulation of encephalitogenic T cells with recombinant TCR ligands","volume":"164","author":"Burrows","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2020.173175_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0006-8993(94)90523-1","article-title":"The effects of methamphetamine and cocaine on motor behavior and extracellular dopamine in the ventral striatum of Lewis versus Fischer 344 rats","volume":"668","author":"Camp","year":"1994","journal-title":"Brain Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2020.173175_bib13","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.bbi.2011.03.003","article-title":"Induction of innate immune genes in brain create the neurobiology of addiction","volume":"25","author":"Crews","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2020.173175_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jeab.121","article-title":"Change in delay discounting and substance reward value following a brief alcohol and drug use intervention","volume":"103","author":"Dennhardt","year":"2015","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.ejphar.2020.173175_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1742-2094-9-97","article-title":"Temporal changes in innate immune signals in a rat model of alcohol withdrawal in emotional and cardiorespiratory homeostatic nuclei","volume":"9","author":"Freeman","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2020.173175_bib16","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.177.11.8072","article-title":"Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2","author":"Gregory","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2020.173175_bib17","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.neuroscience.2009.05.048","article-title":"Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release","volume":"162","author":"Guyon","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2020.173175_bib18","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.177.8.5687","article-title":"Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL\/lpr mice","author":"Hoi","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2020.173175_bib19","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.4049\/jimmunol.150.6.2525","article-title":"Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis","volume":"150","author":"Hulkower","year":"1993","journal-title":"J. Immunol."},{"issue":"Pt B","key":"10.1016\/j.ejphar.2020.173175_bib20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuropharm.2013.05.039","article-title":"Why is neuroimmunopharmacology crucial for the future of addiction research?","volume":"76","author":"Hutchinson","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2020.173175_bib21","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/npp.2015.4","article-title":"CRF-amplified neuronal TLR4\/MCP-1 signaling regulates alcohol self-administration","volume":"40","author":"June","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2020.173175_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.pbb.2006.02.021","article-title":"Differences in extinction responding and reinstatement of methamphetamine-seeking behavior between Fischer 344 and Lewis rats","volume":"83","author":"Kruzich","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2020.173175_bib23","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1001767","article-title":"A small-molecule macrophage migration inhibitory factor Antagonist protects against glomerulonephritis in lupus-prone NZB\/NZW F1 and MRL\/lpr mice","author":"Leng","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2020.173175_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s12640-010-9223-x","article-title":"Methamphetamine causes persistent immune dysregulation: a cross-species, translational report","volume":"20","author":"Loftis","year":"2011","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2020.173175_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-801284-0.00007-5","article-title":"Neuroimmune basis of methamphetamine toxicity","author":"Loftis","year":"2014","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ejphar.2020.173175_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056306","article-title":"Partial MHC\/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction","volume":"8","author":"Loftis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2020.173175_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2014.10.044","article-title":"Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging","volume":"1628","author":"London","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2020.173175_bib28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/cvr\/cvp141","article-title":"Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells","volume":"83","author":"Martin-Ventura","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2020.173175_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2010.09.013","article-title":"RTL therapy for multiple sclerosis: a Phase I clinical study","volume":"231","author":"Offner","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2020.173175_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1515\/REVNEURO.2008.19.4-5.327","article-title":"Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis","volume":"19","author":"Offner","year":"2008","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173175_bib31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12975-014-0345-y","article-title":"Novel humanized recombinant T cell receptor ligands protect the female brain after experimental stroke","volume":"5","author":"Pan","year":"2014","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.ejphar.2020.173175_bib32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1101\/lm.044164.116","article-title":"Persistent effects of acute stress on fear and drug-seeking in a novel model of the comorbidity between post-traumatic stress disorder and addiction","volume":"24","author":"Pizzimenti","year":"2017","journal-title":"Learn. Mem."},{"key":"10.1016\/j.ejphar.2020.173175_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2017.11.042","article-title":"Upregulation of CCL7 and CCL2 in reward system mediated through dopamine D1 receptor signaling underlies methamphetamine-induced place preference in mice","author":"Saika","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2020.173175_bib34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejphar.2020.173175_bib35","doi-asserted-by":"crossref","first-page":"17835","DOI":"10.1523\/JNEUROSCI.3297-11.2011","article-title":"Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression","volume":"31","author":"Schwarz","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173175_bib36","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1523\/JNEUROSCI.1179-08.2008","article-title":"Methamphetamine causes microglial activation in the brains of human abusers","volume":"28","author":"Sekine","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173175_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/jcbfm.2009.240","article-title":"Role of chemokines in CNS health and pathology: a focus on the CCL2\/CCR2 and CXCL8\/CXCR2 networks","volume":"30","author":"Semple","year":"2010","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ejphar.2020.173175_bib38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s002130050608","article-title":"CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats","volume":"137","author":"Shaham","year":"1998","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.ejphar.2020.173175_bib39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11481-009-9175-1","article-title":"Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG","volume":"5","author":"Sinha","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173175_bib40","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1523\/JNEUROSCI.5812-08.2009","article-title":"Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand","volume":"29","author":"Sinha","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173175_bib41","doi-asserted-by":"crossref","first-page":"12531","DOI":"10.1523\/JNEUROSCI.3599-07.2007","article-title":"A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS","volume":"27","author":"Sinha","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173175_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2013.01.016","article-title":"Glial cell modulators attenuate methamphetamine self-administration in therat","author":"Snider","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173175_bib43","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1471-4159.2005.03566.x","article-title":"Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha","volume":"96","author":"Sriram","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2020.173175_bib44","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/npp.2014.309","article-title":"Reductions in frontocortical cytokine levels are associated with long-lasting alterations in reward valuation after methamphetamine","volume":"40","author":"Stolyarova","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2020.173175_bib45","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1161\/STROKEAHA.108.543991","article-title":"Recombinant T cell receptor ligand treats experimental stroke","volume":"40","author":"Subramanian","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2020.173175_bib46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaut.2012.08.004","article-title":"A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance","volume":"40","author":"Vandenbark","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ejphar.2020.173175_bib47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4049\/jimmunol.171.1.127","article-title":"Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice","volume":"171","author":"Vandenbark","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2020.173175_bib48","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2010-0417","article-title":"Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways","volume":"95","author":"Veillat","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2020.173175_bib49","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1523\/JNEUROSCI.21-23-09414.2001","article-title":"Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence","volume":"21","author":"Volkow","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173175_bib50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1254\/jphs.14032FP","article-title":"CC-chemokine ligand 2 facilitates conditioned place preference to methamphetamine through the activation of dopamine systems","volume":"125","author":"Wakida","year":"2014","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2020.173175_bib51","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1471-4159.2006.04081.x","article-title":"Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE","volume":"98","author":"Wang","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2020.173175_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2016.02.036","article-title":"Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study","author":"Worley","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2020.173175_bib53","doi-asserted-by":"crossref","first-page":"27665","DOI":"10.1038\/srep27665","article-title":"Macrophage migration inhibitor factor upregulates MCP-1 expression in an autocrine manner in hepatocytes during acute mouse liver injury","volume":"6","author":"Xie","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173175_bib54","first-page":"954739","article-title":"Recombinant T-cell receptor ligand (RTL) for treatment of multiple sclerosis: a double-blind, placebo-controlled, Phase 1, dose-escalation study","author":"Yadav","year":"2012","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.ejphar.2020.173175_bib55","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbi.2011.09.017","article-title":"Activation of p38 signaling in the microglia in the nucleus accumbens contributes to the acquisition and maintenance of morphine-induced conditioned place preference","volume":"26","author":"Zhang","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2020.173175_bib56","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.neuropharm.2012.07.044","article-title":"Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats","volume":"63","author":"Zhou","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2020.173175_bib57","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11481-016-9673-x","article-title":"Persistent microstructural deficits of internal capsule in one-year abstinent male methamphetamine users: a longitudinal diffusion tensor imaging study","volume":"11","author":"Zhuang","year":"2016","journal-title":"J. Neuroimmune Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:09:14Z","timestamp":1762142954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920302673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":57,"alternative-id":["S0014299920302673"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173175","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Partial MHC\/neuroantigen peptide constructs attenuate methamphetamine-seeking and brain chemokine (C\u2013C motif) ligand 2 levels in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"173175"}}